Elevai Labs, Common Stock Analysis

ELAB Stock   2.49  0.08  3.11%   
Elevai Labs, Common is overvalued with Real Value of 2.39 and Hype Value of 1.95. The main objective of Elevai Labs, stock analysis is to determine its intrinsic value, which is an estimate of what Elevai Labs, Common is worth, separate from its market price. There are two main types of Elevai Labs,'s stock analysis: fundamental analysis and technical analysis.
The Elevai Labs, stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Elevai Labs,'s ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevai Labs, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Elevai Stock Analysis Notes

About 73.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.92. Some equities with similar Price to Book (P/B) outperform the market in the long run. Elevai Labs, Common recorded a loss per share of 88.92. The entity had not issued any dividends in recent years. The firm had 1:200 split on the 27th of November 2024. To learn more about Elevai Labs, Common call the company at 866-794-4940 or check out https://elevaiskincare.com.

Elevai Labs, Quarterly Total Revenue

527,478

Elevai Labs, Common Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Elevai Labs,'s investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Elevai Labs, Common or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Elevai Labs, Common generated a negative expected return over the last 90 days
Elevai Labs, Common has high historical volatility and very poor performance
The company reported the previous year's revenue of 1.71 M. Net Loss for the year was (4.3 M) with profit before overhead, payroll, taxes, and interest of 0.
Elevai Labs, generates negative cash flow from operations
Elevai Labs, Common has a frail financial position based on the latest SEC disclosures
About 73.0% of the company shares are held by company insiders
Latest headline from gurufocus.com: Elevai Biosciences, a Subsidiary of Elevai Labs Inc. ...

Elevai Labs, Common Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Elevai Labs, previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
11th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Elevai Labs, Thematic Classifications

In addition to having Elevai Labs, stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products Idea
Pharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Elevai Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.9 M.

Elevai Profitablity

The company has Profit Margin (PM) of (1.92) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.32) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.32.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.83)(0.87)
Return On Capital Employed(0.94)(0.90)
Return On Assets(0.83)(0.87)
Return On Equity(1.12)(1.07)

Management Efficiency

Elevai Labs, Common has return on total asset (ROA) of (0.8855) % which means that it has lost $0.8855 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.51) %, meaning that it created substantial loss on money invested by shareholders. Elevai Labs,'s management efficiency ratios could be used to measure how well Elevai Labs, manages its routine affairs as well as how well it operates its assets and liabilities. As of December 12, 2024, Return On Tangible Assets is expected to decline to -0.87. The current year's Return On Capital Employed is expected to grow to -0.9. At present, Elevai Labs,'s Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 1.1 M, whereas Non Current Assets Total are forecasted to decline to about 253.4 K.
Last ReportedProjected for Next Year
Book Value Per Share 0.36  0.37 
Tangible Book Value Per Share 0.36  0.37 
Enterprise Value Over EBITDA(920.28)(966.29)
Price Book Value RatioK1.1 K
Enterprise Value Multiple(920.28)(966.29)
Price Fair ValueK1.1 K
Evaluating the management effectiveness of Elevai Labs, allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Elevai Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Operating Margin
(2.32)
Profit Margin
(1.92)
Return On Assets
(0.89)
Return On Equity
(3.51)

Technical Drivers

As of the 12th of December 2024, Elevai Labs, shows the Standard Deviation of 15.65, variance of 245.04, and Mean Deviation of 9.43. Elevai Labs, Common technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Elevai Labs, Common Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Elevai Labs, middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Elevai Labs, Common. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Elevai Labs, Common Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Elevai Labs, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Elevai Labs,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Elevai Labs, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Braeden Lichti over six months ago
Elevai Labs exotic insider transaction detected
 
Beuchler Brenda over six months ago
Elevai Labs exotic insider transaction detected
 
Jp Bio Consulting Llc over six months ago
Elevai Labs exotic insider transaction detected

Elevai Labs, Predictive Daily Indicators

Elevai Labs, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Elevai Labs, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Elevai Labs, Forecast Models

Elevai Labs,'s time-series forecasting models are one of many Elevai Labs,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Elevai Labs,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Elevai Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Elevai Labs, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Elevai shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Elevai Labs,. By using and applying Elevai Stock analysis, traders can create a robust methodology for identifying Elevai entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(2.51)(2.64)
Operating Profit Margin(2.14)(2.25)
Net Loss(2.51)(2.64)
Gross Profit Margin 0.66  0.70 

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Elevai Labs, to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run ETF Categories Now

   

ETF Categories

List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
All  Next Launch Module

Complementary Tools for Elevai Stock analysis

When running Elevai Labs,'s price analysis, check to measure Elevai Labs,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevai Labs, is operating at the current time. Most of Elevai Labs,'s value examination focuses on studying past and present price action to predict the probability of Elevai Labs,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevai Labs,'s price. Additionally, you may evaluate how the addition of Elevai Labs, to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities